CHEST || Practice Economics

Class of 2015: New drugs projected to earn billions and billions

Posted on: 20/04/2015 - 19:43

Of all drugs to be released in 2015, the melanoma drug Opdivo (nivolumab) is expected to have the brightest future, according to a report from Thomson... More »

Field of Interest: Oncology

Type: News Item

Class of 2015: New drugs projected to earn billions and billions

Posted on: 20/04/2015 - 19:43

Of all drugs to be released in 2015, the melanoma drug Opdivo (nivolumab) is expected to have the brightest future, according to a report from Thomson... More »

Field of Interest: Dermatology

Type: News Item

CMS proposes lung cancer screening with low-dose CT for high-risk patients

Posted on: 10/11/2014 - 22:41

Medicare patients who are at high risk for lung cancer would be able to get screening using low-dose computed tomography under a proposed national coverage decision announced Nov. 10. “The evidence...

Field of Interest: Oncology

Type: News Item

Medical consultation rates for surgical cases vary

Posted on: 12/08/2014 - 16:55

The use of inpatient medical consultations for hospitalized surgical patients was found to vary by hospital, but consultations didn’t appear to have much of an impact on risk-adjusted 30-day...

Field of Interest: Oncology

Type: News Item

Medical consultation rates for surgical cases vary

Posted on: 12/08/2014 - 16:55

The use of inpatient medical consultations for hospitalized surgical patients was found to vary by hospital, but consultations didn’t appear to have much of an impact on risk-adjusted 30-day...

Field of Interest: Gastroentero...

Type: News Item

Medicare asks experts to weigh in on low-dose CT lung cancer screening

Posted on: 25/04/2014 - 13:00

Should Medicare pay for low-dose computed tomography to screen certain patients for lung cancer? A panel of expert advisers will meet April 30 to review the evidence and make a recommendation. The...

Field of Interest: Oncology

Type: News Item

Class of 2015: New drugs projected to earn billions and billions

Class of 2015: New drugs projected to earn billions and billions

CMS proposes lung cancer screening with low-dose CT for high-risk patients

Medical consultation rates for surgical cases vary

Medical consultation rates for surgical cases vary

Medicare asks experts to weigh in on low-dose CT lung cancer screening

Newsletters

Latest Newsletters

You are here

CHEST || Practice Economics

Class of 2015: New drugs projected to earn billions and billions

Class of 2015: New drugs projected to earn billions and billions

CMS proposes lung cancer screening with low-dose CT for high-risk patients

Medical consultation rates for surgical cases vary

Medical consultation rates for surgical cases vary

Medicare asks experts to weigh in on low-dose CT lung cancer screening

Newsletters

Latest Newsletters